AU2011203552B2 - New and gentle process for conversion of cystine in keratin-containing materials to lanthionine - Google Patents

New and gentle process for conversion of cystine in keratin-containing materials to lanthionine Download PDF

Info

Publication number
AU2011203552B2
AU2011203552B2 AU2011203552A AU2011203552A AU2011203552B2 AU 2011203552 B2 AU2011203552 B2 AU 2011203552B2 AU 2011203552 A AU2011203552 A AU 2011203552A AU 2011203552 A AU2011203552 A AU 2011203552A AU 2011203552 B2 AU2011203552 B2 AU 2011203552B2
Authority
AU
Australia
Prior art keywords
keratin
composition
proteins
cystine
isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011203552A
Other versions
AU2011203552A1 (en
Inventor
Keith Edward Branham
Donald R. Cowsar
James Perry English
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Keraplast Technologies Ltd
Original Assignee
Keraplast Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keraplast Technologies Ltd filed Critical Keraplast Technologies Ltd
Priority to AU2011203552A priority Critical patent/AU2011203552B2/en
Publication of AU2011203552A1 publication Critical patent/AU2011203552A1/en
Application granted granted Critical
Publication of AU2011203552B2 publication Critical patent/AU2011203552B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

ABSTRAC' Useful materials are produced from keratin containing raw materials by a process that includes gentle lanthionization of cystine disulfide bonds. Hydratable materials are produced for use in medical and cosmetic applications.

Description

AUSTRALIA Regulation 3.2 Patents Act 1990 Complete Specification Standard Patent APPLICANT: Keraplast Technologies, Ltd Invention Title: NEW AND GENTLE PROCESS FOR CONVERSION OF CYSTINE IN KERATIN-CONTAINING MATERIALS TO LANTHIONINE The following statement is a full description of this invention, including the best method of performing it known to me: Title of Invention New and Gentle Process for Conversion of Cystine in Keratin-Containing Materials to Lanthionine Background of the Invention 5 [0001] In proteins such as keratin, a cystine bond forming an intraprotein or interprotein link is characterized as R-C-S-S-C-R in which the C-R represents the cystine amino acid as pail of a protein polypeptide and the two chains are joined by the S-S bond. This S-S bond can be broken by reduction of the Sulfur to S-H or it can be broken by oxidation to give a sulfonic acid residue, SO.. Other possibilities include a substitution in which another sulfur containing 10 moiety such as meiraptoethanol or thioglycolate are bonding to one or both sides of the cystine bond. Of these, all but the oxidation reaction are reversible and the cystine disulfide can be reformed. Oxidation of the sulfur blocks reformation of the cystine S-S bond. Lanthionization has been known for use in cosmetic treatments (see US Patents 3,908,672 and 3,971,391). A lanthionized disulfide loses one of the sulfur atoms and would be represented as R-C-S-C-R. 15 This is also an irreversible reaction allowing one to control the amount 6f subsequent oxidation of the material. 100021 In the case of keratin proteins, it is often desirable to manipulate the character of the cysteine sulfurs by partially oxidizing the material and then neutralizing the product to produce a hydrogel forming material. By controlling the number of oxidized sulfurs, the 20 characteristics of the hydrogel material can also be controlled. [0003J Lanthionization as disclosed for use in cosmetic treatments was done in an aqueous medium using hydroxide base, specifically LiOH, fi-equently at elevated temperatures and was applied to living human hair. The present inventors have found that application of this living hair technology to keratin containing raw materials and particularly wool fabric produced 25 materials that were too fragile for certain applications or in some cases completely degraded. The present disclosure expands the use of lanthionization processes to a means of preparing new and improved materials for biomedical and other applications. Summary [0004] The present disclosure provides novel keratin containing materials and methods of 30 producing the novel materials that provide numerous advantages over previously known methods. The methods include at least partial lanthionization of cystine disulfide bonds in a controlled manner. The process may be used to lanthionize raw, animal-derived materials (for example, wool staple) or any keratin containing fabric or fabric blend. The process, when used to treat wool fabric, yields fabric with greater elasticity than the untmated fabric. [0005) The lanthionization process offers at least the following advantages over controlled oxidation, including the conduction of lanthionization under unusually mild condition, ie. at 5 ambient temperature with no external agitation, and conducting the reaction under non-aqueous or semi-aqueous conditions. The process is unusually clean. The only products of the reaction are lanthionine (thioether linkages) and H 2 S gas. The residual H 2 S is removed by washing with water and by vacuum drying. The process provides the further advantage that it can be carried out continuously. 10 [00061 As found in the literature, keratin materials such as hair and wool may be fractionated into water soluble and water insoluble fractions. The water insoluble portion is known as f-kcmtin and has been refened to as "IKP" and IKP that has been ion exchanged is called "HXP" (hydratable keratin protein) by the applicants. The water soluble fraction contains a low sulfur portion and a high sulfur portion. The low sulfur portion is known as a 15 keratin or a-keratose when oxidized, and the high sulfur portion is known as y-keratin. [0007] Throughout this disclosure, unless the context dictates otherwise, the word "comprise" or variations such as "comprises" or "comprising," is understood to mean "includes, but is not limited to" such that other elements that arc not explicitly mentioned may also be included. Further, unless the context dictates otherwise, use of the term "a" may mean a 20 singular object or element, or it may mean a pluality, or one or more of such objects or elements. Detailed Description [0008) The present invention involves a process for the treatment of keratin-containing raw materials from mammalian sources, such raw materials including, but not limited to hair, 25 wool, fur, skin, horn, hooves, or bird feet, beaks, and feathers and any fabric composed wholly or partly of keratin, both woven and non-woven, and including blends with other natural and synthetic fibers such as cotton, nylon, rayon, silk, polyester etc. The treatment results in at least partial conversion of the disulfide groups (R-S-S-R) of the cystine residues in keratin to lanthionine residues (thioether groups, R-S-R) in a process know as lanthionization. The 30 treatment is conducted in non-aqueous or semi-aqueous medium with a base such as a hydroxide base including but not limited to NaOI, KOH, NH 4 0H, and the like, at ambient or sub-ambient temperature in alcohols such as ethanol, methanol and isopropanol or in any of the polar aprotic solvents such as dimethylformamide (DMF), dimethyldisulfoxide (DMSO), N-methylpyrolidone (NMP). hexamethylphosphoramide (HMPA), and the like. The reaction 2 medium may also contain water in varying amounts. One may control the rate or degree of lanthionization, by adjusting the water content of the reaction medium. [00091 The replacement of the cystine residues with lanthionine results in the formation of permanent (essentially unreactive) thioether linkages (R-S-R) in place of the disulfide linkages 5 (R-S-S-R) that can be cleaved by a number of methods. One important method of cleavage involves some existing technology that teaches the oxidation of raw animal products containing keratin (hair, wool, fur skin, horn, hooves, or bird feet, beaks, and feathers) to produce a keratin product containing sulfonic acid groups that is insoluble and may be used to produce a hydrogel material (for example, see US patent 6,316,598 assigned to Keraplast 10 Technologies, Ltd.) [000101 The present disclosure offers an improvement over the previously disclosed methods by providing the opportunity to better control the number of sulfonic acid groups produced during the oxidation process by using lanthionization as a pretreatment The use of the lanthionization process prior to oxidation also allows the preparation higher molecular 15 weight (MW) keratin derivatives than those produced using oxidation alone by preserving crosslinks that would be broken by oxidation. This is true for both the soluble and insoluble keratin derivatives produced upon oxidation. Thus, the present disclosure provides the ability to form permanent thioether crosslinks that result in higher MW products, while simultaneously controlling the number of sulfonic acid residues present in the material. Using 20 the disclosed methods (lanthionization) in conjunction with oxidation provides the opportunity to tailor biomaterials containing keratin to specific applications by controlling the MW, the degree of permanent crosslinking, and the number of sulfonic acid groups present. Description of Preferred Embodiments of the Process [000111 In one embodiment of a process for producing the disclosed materials, 125 g of 25 wool staple were transferred to l one gallon jar, mixed with 1.5 L of 1.5% w/v KOH in ethanol (EtOH) and sealed with a lid. Care was taken to insure that the wool staple was completely covered and the mixture was allowed to stand undisturbed for approximately 16-18 hours. Next, the wool staple was isolated by vacuum filtration, washed with two 1 L portions of deionized water and transferred to a Teflon-lined glass dish. The wool staple exhibited the 30 characteristic odor of hydrogen sulfide (I 2 S) gas. The lanthionized wool staple was air dried for approximately 4 hours then vacuum dried for approximately 20 hours to yield the final product. 3 [00012] In another embodiment of the process fifteen squares (35.6g) of fabric, worsted wool flannel, were transferred to a 1 L glass jar, mixed with 750 mL of 1.5% w/v KOH/EtOH, and sealed with a lid. The reaction was allowed to proceed approximately 20 hours. Next the fabric was isolated by gravity filtration and washed with two 800 mL portions of deionized 5 water, wrung dry and transferred to a teflon-lined glass dish. At this time the wool fabric exhibited the characteristic odor of H 2 S. The lanthionized worsted wool flannel was dried under vacuum to yield the final product The lanthionized wool fabric had significantly more elasticity than the untreated fabric. [00013] In certain embodiments, the present disclosure includes the use of keratin 10 containing raw materials such as hair, wool, or feathers, or the use of soluble and insoluble keratin materials isolated from keratin containing raw materials. Keratin containing raw materials can be fractionated by breaking the disulfide bonds that form intramolecular or intermolecular bridges using oxidative or reductive chemistries. 1000141 The present disclosure provides methods for controlled lanthionization of the 15 keratin materials or proteins. Lanthionization provides numerus advantages over prior methods of making and using these materials. As described above, mild lanthionization of wool fabric gives the fabric greater elasticity. In a wool blend fabric in which wool fibers run in one direction and a non-keratin material fiber runs in the perpendicular direction, then elasticity can be imparted in a single direction, for example. 20 [000151 In certain preferred embodiments, the lanthionization process can be used in conjunction with oxidation in the production of keratin gels or hydrogels. One of the goals in producing these materials has been the ability to control the number of cystine residues that are oxidized. This has previously been controlled by the concentration of oxidant and by reaction time and temperature. Lanthionization of a portion of the cystines blocks the lanthionine 25 residues from further oxidation under mild conditions. The lanthionized keratin material may then be oxidized to produce cysteic acid groups from at least a portion of the remaining cystines. A preferred method of oxidation is to place the keratin material in 2%H 2 0 2 at 100*C for 1.5 hours, followed by vacuum filtration, washing in distilled deionized water and vacuum drying. 30 100016] In a further embodiment, the lanthionized and oxidized material is ion exchanged, or contacted with an ion containing solution to allow the positively charged ions, or cations, to replace hydrogen ions, or to associate with negatively charged regions in the keratin material. Ion exchange may preferably be accomplished by placing the keratin material in a solution 4 containing a cationic species such as ammonium, sodium, potassium, or calcium ions. A preferred solution for ion exchange of keratin materials is soaking the material in a solution of 0.1M NH 4 0H for a period of about 8-12 hours. [00017] The lanthionized/oxidized or lanthionized/oxidized/ion exchanged keratin 5 materials when dried, or dried and ground are hydratable and form gels or hydrogels upon uptake of water. Such hydrated or hydratable materials are useful in various applications, including in medical applications such as bandages, sheets, tissue expanding materials, implants, cell scaffolding, as well as in cosmetic applications. [00018 The hydratable quality of these materials makes them especially useful in the area 10 of bandages or absorbents to be placed on a wound. In certain embodiments, for example, lanthionized or lanthionized and oxidized keratin proteins may be adsorbed into a cotton gauze pad for placement on a wound. The keratin material in the cotton enhances the absorbency of any liquids leaking or oozing from the wound. In addition, the keratin materials may be rehydrated with a solution containing active substances such as antibiotics, analgesics, 15 cytokines, or growth factors, to aid the healing process. In certain embodiments, a pocket may be formed of cotton gauze and the keratin material may be contained in the pocket such that one layer of cotton gauze is placed against a wound and the other layer may be placed against an impermeable or adhesive backing to produce an absorbent bandage. [00019) The disclosed materials may also be used in the production of transparent film 20 materials, for example. In one embodiment, 1 gram samples of oxidized, dry and ground @ keratose or lanthionized, oxidized S-keratose are prepared on 5 inch squares of aluminum foil. Any of the samples may also be ion exchanged prior to production of the films. Ie granular solid is distributed as unifonnly as possible, arranged in a square roughly 1.5 inches on each side. Next, the sample of each solid are treated with a solution of plasticizer, 20% w/w glycerol 25 in methanol. The amount of plasticizer solution used may vary from 17% up to about 35% w/w. The samples are allowed to dry and then pressed in a Carver press using a load of 8,000 to 8,500 pounds at approximately 130*C for 10 minutes. The films produced by this method are transparent to semi-transparent and somewhat flexible, and are reminiscent of skin. Such films are useful as wound coverings or implant materials, and may also be formed into three 30 dimensional shapes for implant or bulking material applications. [00020] Numerous advantages of the disclosed compositions and processes have been set forth in the foregoing description, as exemplified by the disclosed preferred embodiments. It will be understood by those of skill in the art, however, that changes may be made in details, 5 particularly in matters of reagents, concentrations, and step order, that do not require undue experimentation. All such changes in materials or processes are understood to be equivalent variants of the disclosure and to fall within the spirit and scope of the invention. The reference to any prior art in this specification is not, and should not be taken as an 5 acknowledgement or any form of suggestion that prior art forms part of the common general knowledge in Australia. 6

Claims (31)

  1. 2. The composition of claim 1, wherein the isolated keratin material is human hair or skin; or animal wool, hair, skin, fur, horn, or hooves; or avian feathers, beaks or feet.
  2. 3. The composition of claim 1, wherein the isolated keratin material is a woven fabric.
  3. 4. The composition of claim 3, wherein the fabric is a wool fabric.
  4. 5. The composition of claim 3, wherein the fabric is wool blended with cotton, polyester, rayon, silk, or nylon.
  5. 6. The composition of claim 1, wherein about 50% of the cystine disulfide bonds have been replaced with lanthionine residues.
  6. 7. The composition of claim 1, wherein from 5% to about 50% of the cystine disulfide bonds have been replaced with lanthionine residues.
  7. 8. The composition of claim 1, wherein from 10% to about 50% of the cystine disulfide bonds have been replaced with lanthionine residues.
  8. 9. The composition of claim 1, wherein the base is NaOH, KOH, N1H 4 0H, LiOH, or Ca(OH) 2 .
  9. 10. The composition of claim 9 wherein the base is about 1.5% KOH.
  10. 11. The composition of claim 1, wherein the reaction medium comprises an alcohol or an aprotic solvent. 7
  11. 12. The composition of claim 1, wherein the reaction medium comprises ethanol, methanol, isopropanol, dimethylformamide, dimethyldisulfoxide, N-methylpyrrolidione, or hexamethylphosphoramide.
  12. 13. The composition of claim 1, wherein the lanthionine residues are produced in non-hydrolyzing conditions.
  13. 14. The composition of claim 13, wherein the non-hydrolyzing conditions comprise a temperature of from 20-30'C and a non-aqueous reaction medium.
  14. 15. The composition of claim 1, wherein the isolated keratin material comprises keratin proteins.
  15. 16. The composition of claim 1, wherein the isolated keratin material comprises a keratin proteins.
  16. 17. The composition of claim 1, wherein the isolated keratin material comprises y keratin proteins.
  17. 18. A bandage comprising a layer of dried, lanthionized, ion-exchanged keratin material.
  18. 19. The bandage of claim 18 comprising a layer of cotton gauze and a layer of dried, lanthionized, ion-exchanged keratin material.
  19. 20. The bandage of claim 19, comprising a second layer of cotton gauze.
  20. 21. The bandage of any one of claims 18-20, further comprising a backing material.
  21. 22. The bandage of any one of claims 18-21, wherein the keratin material is oxidized.
  22. 23. A composition comprising isolated keratin proteins comprising cystine residues wherein a first portion of the cystine residues are converted to lanthionine and subsequently a second portion of the cystine residues are converted to cysteic acid. 8
  23. 24. The composition of claim 23, further comprising cations associated with negatively charged regions of the proteins.
  24. 25. The composition of claim 23, wherein the isolated keratin proteins are water insoluble p-keratin proteins.
  25. 26. A method of producing a hydratable keratin material comprising: a) Incubating a keratin protein material in a solution of 1.5% KOH in an alcohol or aprotic solvent at a temperature of 20-30'C for a time of about 18-24 hours and removing the solvent to obtain a lanthionized keratin protein material; and b) Incubating the lanthionized keratin protein material in a solution of 0.1M NH 4 0H for a period of about 8-12 hours and drying the keratin protein material to obtain a hydratable keratin protein material.
  26. 27. The method of claim 26, wherein the keratin protein material is produced by isolating water insoluble keratin proteins from a keratin raw material.
  27. 28. The method of claim 27, further comprising incubating the keratin protein material in a solution of 2% H 2 0 2 at 100 0 C for 1.5 hours.
  28. 29. The method of claim 28, wherein the incubation in 2% H 2 0 2 is done prior to step a).
  29. 30. A composition substantially as herein disclosed with reference to the detailed description.
  30. 31. A bandage substantially as herein disclosed with reference to the detailed description.
  31. 32. A method of producing a hydratable keratin material substantially as herein disclosed with reference to the detailed description. 9
AU2011203552A 2004-06-10 2011-07-07 New and gentle process for conversion of cystine in keratin-containing materials to lanthionine Ceased AU2011203552B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2011203552A AU2011203552B2 (en) 2004-06-10 2011-07-07 New and gentle process for conversion of cystine in keratin-containing materials to lanthionine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60/578,786 2004-06-10
AU2011203552A AU2011203552B2 (en) 2004-06-10 2011-07-07 New and gentle process for conversion of cystine in keratin-containing materials to lanthionine

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2005254987A Division AU2005254987A1 (en) 2004-06-10 2005-06-09 New and gentle process for conversion of cystine in keratin-containing materials to lanthionine

Publications (2)

Publication Number Publication Date
AU2011203552A1 AU2011203552A1 (en) 2011-08-04
AU2011203552B2 true AU2011203552B2 (en) 2011-10-27

Family

ID=45420425

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011203552A Ceased AU2011203552B2 (en) 2004-06-10 2011-07-07 New and gentle process for conversion of cystine in keratin-containing materials to lanthionine

Country Status (1)

Country Link
AU (1) AU2011203552B2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2401479A (en) * 1939-10-30 1946-06-04 Tootal Broadhurst Lee Co Ltd Treatment of wool
US3908672A (en) * 1973-03-08 1975-09-30 Oreal Novel process for improving and modifying the properties of hair

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2401479A (en) * 1939-10-30 1946-06-04 Tootal Broadhurst Lee Co Ltd Treatment of wool
US3908672A (en) * 1973-03-08 1975-09-30 Oreal Novel process for improving and modifying the properties of hair

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HORN, M.J. et al.: Isolation of a New Sulfur-Containing Amino Acid (Lathionine) from Sodium Carbonate-Treated Wool, The Journal of Biological Chemistry, Volume 138, 1941, pages 141-149 *
HORN, M.J. et al.: Isolation of Mesalanthionine from Various Alkali-Treated Proteins, The Journal of Biological Chemistry, Volume 144, 1942, pages 87-91 *
LINDLEY, H. et al., The Action of Alkalis on Wool, Biochemical Journal, Volume 39, 1945, pages 17-23 *

Also Published As

Publication number Publication date
AU2011203552A1 (en) 2011-08-04

Similar Documents

Publication Publication Date Title
US11124611B2 (en) Cosmetic sponge and method for providing a cosmetic sponge
US6316598B1 (en) Water absorbent keratin and gel formed therefrom
EP1241178A1 (en) Process for producing functional silk fibroin and utilization of the same
EP1766125B1 (en) New and gentle process for conversion of cystine in keratin-containing materials to lanthionine
EA005697B1 (en) A method for preparing a collagen sponge
WO2010110067A1 (en) Crosslinked material comprising elastin and collagen, and use thereof
EA011388B1 (en) Wound care products containing keratin
CN110384818A (en) A kind of alginate dressing
CN103059333A (en) Method for preparing rehydration bacterial cellulose membrane by utilizing vegetable protein and hydrolysate thereof
US20080262632A1 (en) Method for Producing Biomaterials From Bone Tissue and Material Used for Osteoplasty and Tissue Engineering
EP1888099B1 (en) Hydratable keratin compositions
WO2005124011A1 (en) Keratin based hydrogel sheets prepared from fabric for biomedical and other applications and method of production
JPS58170721A (en) Hydrophilic biopolymer copolyelectrolyte
AU2011203552B2 (en) New and gentle process for conversion of cystine in keratin-containing materials to lanthionine
US8124735B2 (en) Porous keratin construct and method of making the same
JPH06145060A (en) Composition for wound coating material
RU2108114C1 (en) Biological composition to treat wounds
RU2430743C2 (en) Biologically active wound covering
KR101000537B1 (en) Collagen patch base and fabrication method thereof
JPH05184662A (en) Artificial skin and its manufacture
Jaiswar et al. 1Department of Chemistry, Dr. Bhimrao Ambedkar University, Agra, India, 2Department of Chemistry, IET, Dr. Bhimrao Ambedkar University, Agra, India
JPH03206032A (en) Wound-covering material
BG109565A (en) Multilayer bioresorbable membrane for guided tissue regeneration

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired